Pharmaceutical Raw Materials Respiratory System Drugs Roflumilast for COPD 162401-32-3

 Pharmaceutical Raw Materials Respiratory System Drugs Roflumilast for COPD 162401-32-3

Basic Info.

Roflumilast

Synonyms: ROFLUMILAST;3-(Cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide;B 9302-107;BY 217;BYK 20869;Daxas;Roflumilast / 3-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide;3-(Cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide 

CAS: 162401-32-3 

MF: C17H14Cl2F2N2O3 

MW: 403.21 

MP: 158°C 

storage temp.  Refrigerator 

Chemical Properties Crystallin Solid 

Usage Selective phosphodiesterase 4(PDE4) inhibitor. Antiasthmatic; in treatment of chronic obstructive pulmonary disease 

Purity: 99%

Usage: API

Package: 1KG foil bag; 25Kg drum

Description:

Roflumilast is a phosphodiesterase-4 (PDE-4) inhibitor. Due to its selective inhibition of the PDE4 isoenzyme in lung cells, roflumilast is indicated for the management of chronic obstrtuctive pulmonary disease (COPD) exacerbations. Treatment with Roflumilast is associated with an increase in psychiatric adverse reactions, including suicide and suicidal attempts.